By Charles Benoit, CPA Trade Counsel Last month, President Biden stunned the trade community around the world when he announced a two-year legal immunity from
The House Armed Services Committee passed its version of the National Defense Authorization Act this week, with many amendments taking swipes at China reliance.
The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
Harry Moser of the Reshoring Initiative gives his assessment of America’s reshoring efforts in testimony to the U.S. China Economic and Security Review Commission.